All calculations assume proper laboratory handling, sterile technique, and appropriate storage conditions
Ozempic, a drug primarily used to treat type 2 diabetes and lose weight, has been linked to certain vision problems, particularly Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)
NEDA cautions that for people with active eating disorders or a history of disordered eating, these drugs can be harmful when not used for their intended purpose, when inadequately monitored or monitored by clinicians without eating disorder expertise, or when used for weight loss motivated by weight stigma. That doesnt mean GLP-1s are automatically off the table, but it does mean that this decision warrants extra care, specialist input, and close monitoring throughout
Structured, balanced eating is genuinely helpful, and a sustainable way of eating is part of any lasting result
For weight management (semaglutide 2.4 mg/Wegovy), NICE recommends stopping treatment if less than 5% of initial body weight is lost at 6 months
